Related Experiment Videos

Pneumocystis carinii is resistant to imidazole antifungal agents

M S Bartlett1, S F Queener, M M Shaw

  • 1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis 46202-5120.

Insights

Imidazole antifungal drugs are ineffective against Pneumocystis carinii pneumonia. This is because P. carinii lacks ergosterol, the primary target of these antifungal agents.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pneumocystis carinii pneumonia (PCP) is a serious opportunistic infection.
  • Given the fungal relationship of P. carinii, antifungal imidazole drugs were investigated for PCP treatment.

Purpose of the Study:

  • To evaluate the efficacy of six imidazole antifungal drugs against P. carinii.
  • To determine the mechanism behind the ineffectiveness of imidazoles against P. carinii.

Main Methods:

  • In vitro screening of six imidazole drugs against P. carinii in short-term cultures.
  • In vivo testing of imidazole drugs in infected rats.
  • Analysis of P. carinii cell membranes for the presence of ergosterol.

Main Results:

  • None of the tested imidazole drugs demonstrated significant efficacy in vivo in infected rats.
  • Only miconazole exhibited minimal activity in vitro at a high concentration (10 µg/ml).
  • Cell membrane analysis revealed the absence of ergosterol in P. carinii.

Conclusions:

  • Imidazole antifungal drugs are not effective for treating P. carinii pneumonia.
  • The absence of ergosterol in P. carinii explains the lack of response to imidazole therapy.

Related Concept Videos